High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis
Hepatotoxicity is one of the most cited reasons for withdrawal of approved drugs from the market. The use of nonclinically relevant in vitro and in vivo testing systems contributes to the high attrition rates. Recent advances in differentiating human induced pluripotent stem cells (hiPSCs) into pure...
Gardado en:
Main Authors: | Arvind Pradip (Author), Daniella Steel (Author), Susanna Jacobsson (Author), Gustav Holmgren (Author), Magnus Ingelman-Sundberg (Author), Peter Sartipy (Author), Petter Björquist (Author), Inger Johansson (Author), Josefina Edsbagge (Author) |
---|---|
Formato: | Libro |
Publicado: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Highly Synchronized Expression of Lineage-Specific Genes during In Vitro Hepatic Differentiation of Human Pluripotent Stem Cell Lines
por: Nidal Ghosheh, et al.
Publicado: (2016) -
Amiodarone Hepatotoxicity with Absent Phospholipidosis and Steatosis: A Case Report and Review of Amiodarone Toxicity in Various Organs
por: Adela Cimic, et al.
Publicado: (2013) -
Drug-induced phospholipidosis - causes, effects, identification
por: Agnieszka Katarzyna Gonet-Surówka, et al.
Publicado: (2023) -
Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes
por: Jenifer Trepiana, et al.
Publicado: (2020) -
A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis
por: Maddalena Parafati, et al.
Publicado: (2018)